Controls will be children born 2 months prior to the availability of Rotarix at each site who were enrolled in the active surveillance program at either site and who tested negative for rotavirus. Children who have been previously hospitalized for diarrhea, who have a sibling enrolled in the study, or who have recently moved into the study area (and might not have been eligible for the vaccine) will be excluded.